Cantor Fitzgerald: The trial results from J&J's COVID vaccine are very important to public perceptio
Published Date: 1/26/2021
Source: CNBC Television
Louise Chen, specialty pharma analyst at Cantor Fitzgerald, discusses Johnson & Johnson's path for its potential COVID-19 vaccine, and how that could impact the company's results.
